Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 18, 2021
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19
Thomas J Esparza, Yaozong Chen, Negin P Martin, et al.
Mabs
|
March 15, 2022
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19
Thomas J Esparza, Yaozong Chen, Negin P Martin, et al.
Acta Pharmaceutica Sinica. B
|
September 30, 2021
Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
Xiang Li, Neelakshi Gohain, Si Chen, et al.
Biochimica Et Biophysica Acta. Biomembranes
|
January 19, 2019
Systematic mutational analysis of human neutrophil α-defensin HNP4
Han Hu, Bin Di, William D Tolbert, et al.
Structure (London, England : 1993)
|
October 24, 2017
Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 Region
William D Tolbert, Neelakshi Gohain, Nirmin Alsahafi, et al.
Journal of Virology
|
August 23, 2019
The HIV-1 Antisense Protein ASP Is a Transmembrane Protein of the Cell Surface and an Integral Protein of the Viral Envelope
Yvonne Affram, Juan C Zapata, Zahra Gholizadeh, et al.
ACS Medicinal Chemistry Letters
|
November 20, 2024
Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity
Daniel Lee, Ling Niu, Shilei Ding, et al.
The Journal of Infectious Diseases
|
September 24, 2025
Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV
Mehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
Journal of Virology
|
December 10, 2020
Stabilizing the HIV-1 envelope glycoprotein State 2A conformation
Dani Vézina, Shang Yu Gong, William D Tolbert, et al.
Vaccines
|
September 28, 2021
Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
Rebekah Sherburn, William D Tolbert, Suneetha Gottumukkala, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Biorxiv : the Preprint Server for Biology
|
November 18, 2021
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19
Thomas J Esparza, Yaozong Chen, Negin P Martin, et al.
Mabs
|
March 15, 2022
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19
Thomas J Esparza, Yaozong Chen, Negin P Martin, et al.
Acta Pharmaceutica Sinica. B
|
September 30, 2021
Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
Xiang Li, Neelakshi Gohain, Si Chen, et al.
Biochimica Et Biophysica Acta. Biomembranes
|
January 19, 2019
Systematic mutational analysis of human neutrophil α-defensin HNP4
Han Hu, Bin Di, William D Tolbert, et al.
Structure (London, England : 1993)
|
October 24, 2017
Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 Region
William D Tolbert, Neelakshi Gohain, Nirmin Alsahafi, et al.
Journal of Virology
|
August 23, 2019
The HIV-1 Antisense Protein ASP Is a Transmembrane Protein of the Cell Surface and an Integral Protein of the Viral Envelope
Yvonne Affram, Juan C Zapata, Zahra Gholizadeh, et al.
ACS Medicinal Chemistry Letters
|
November 20, 2024
Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity
Daniel Lee, Ling Niu, Shilei Ding, et al.
The Journal of Infectious Diseases
|
September 24, 2025
Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV
Mehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
Journal of Virology
|
December 10, 2020
Stabilizing the HIV-1 envelope glycoprotein State 2A conformation
Dani Vézina, Shang Yu Gong, William D Tolbert, et al.
Vaccines
|
September 28, 2021
Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
Rebekah Sherburn, William D Tolbert, Suneetha Gottumukkala, et al.
Page
of 8